this post was submitted on 16 Sep 2023
1165 points (96.1% liked)

Technology

59080 readers
4277 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 1 year ago
MODERATORS
 

Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

you are viewing a single comment's thread
view the rest of the comments
[–] arc@lemm.ee 6 points 1 year ago (1 children)

Notably they trialled first for coeliac autoimmune, but it'll be 2024 before phase 2 results are out for that. About 10 years back there was a similar vaccine which also passed phase 1 trials but failed at phase 2. Phase 1 is basically testing that the vaccine does no harm in small groups and it is phase 2 where they measure if it is actually efficacious and to what level. If it passes phase 2, then get your hopes up.

[–] BroccoliFarts@lemmy.world 2 points 1 year ago

I work in clinical (and preclinical) trials. And I have celiac disease. I'm hopeful but not optimistic that I'll be able to eat pasta within the next decade.